Aberrant TNF signalling in dendritic cells in the absence of XIAP contributes to X-linked lymphoproliferative disease (XLP-2) by exaggerated necroptosis

Aberrant TNF signalling in dendritic cells in the absence of XIAP contributes to X-linked lymphoproliferative disease (XLP-2) by exaggerated necroptosis

Bibliographic Details
Main Authors:	Yabal, M, Mueller, N, Adler, H, Knies, N, Gross, C, Damgaard, R, Kanegane, H, Ringelhan, M, Kaufmann, T, Heikenwaelder, M, Strasser, A, Gross, O, Ruland, J, Peschel, C, Gyrd-Hansen, M, Jost, P
Format:	Journal article
Published:	2014

Similar Items

XIAP restricts TNF- and RIP3-dependent cell death and inflammasome activation.
by: Yabal, M, et al.
Published: (2014)

XIAP Restricts TNF- and RIP3-Dependent Cell Death and Inflammasome Activation
by: Yabal, M, et al.
Published: (2014)

XIAP Restricts TNF- and RIP3-Dependent Cell Death and Inflammasome Activation
by: Monica Yabal, et al.
Published: (2014-06-01)

Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency).
by: Pachlopnik Schmid, J, et al.
Published: (2011)

The ubiquitin ligase XIAP recruits LUBAC for NOD2 signaling in inflammation and innate immunity.
by: Damgaard, R, et al.
Published: (2012)

Disease-causing mutations in the XIAP BIR2 domain impair NOD2-dependent immune signalling.
by: Damgaard, R, et al.
Published: (2013)

RIPK2 NODs to XIAP and IBD
by: Topal, Y, et al.
Published: (2020)

Identification of a novel primary immunodeficiency syndrome leading to an XLP-like phenotype in girls
by: Huck, K, et al.
Published: (2009)

Molecular pathogenesis of EBV susceptibility in XLP as revealed by analysis of female carriers with heterozygous expression of SAP.
by: Umaimainthan Palendira, et al.
Published: (2011-11-01)

Systemic Epstein–Barr Virus-Positive T/NK Lymphoproliferative Diseases With SH2D1A/XIAP Hypomorphic Gene Variants
by: Masataka Ishimura, et al.
Published: (2019-05-01)

X-linked inhibitor of apoptosis (XIAP) deficiency: the spectrum of presenting manifestations beyond hemophagocytic lymphohistiocytosis.
by: Speckmann, C, et al.
Published: (2013)

Advances in Understanding the Pathogenesis of Epstein-Barr Virus-Associated Lymphoproliferative Disorders
by: Xi Yang, et al.
Published: (2015-10-01)

The long noncoding RNA XIAP-AS1 promotes XIAP transcription by XIAP-AS1 interacting with Sp1 in gastric cancer cells.
by: Jun Cai, et al.
Published: (2017-01-01)

CYLD limits Lys63- and Met1-linked ubiquitin at receptor complexes to regulate innate immune signaling
by: Gyrd-Hansen, M, et al.
Published: (2016)

Exaggerated Emphasis
by: Peter McCue
Published: (2014-05-01)

A new functional assay for the diagnosis of X-linked inhibitor of apoptosis (XIAP) deficiency.
by: Ammann, S, et al.
Published: (2014)

XIAP’s Profile in Human Cancer
by: Huailu Tu, et al.
Published: (2020-10-01)

Gene therapy for X-linked Inhibitor of Apoptosis Protein (XIAP) deficiency
by: Topal, Y, et al.
Published: (2017)

The X-linked inhibitor of apoptosis protein (XIAP) is up-regulated in metastatic melanoma, and XIAP cleavage by Phenoxodiol is associated with Carboplatin sensitization
by: Camp Robert L, et al.
Published: (2007-01-01)

XIAP Regulates Caspase Activity in Degenerating Axons
by: Nicolas Unsain, et al.
Published: (2013-08-01)

Evolution of Our Understanding of XIAP Deficiency
by: Anne C. A. Mudde, et al.
Published: (2021-06-01)

Inhibitor of apoptosis (IAP) proteins in regulation of inflammation and innate immunity.
by: Damgaard, R, et al.
Published: (2011)

Genome Editing With TALEN, CRISPR-Cas9 and CRISPR-Cas12a in Combination With AAV6 Homology Donor Restores T Cell Function for XLP
by: Benjamin C. Houghton, et al.
Published: (2022-05-01)

Reports of the death of the epistasis model are greatly exaggerated.
by: Farrall, M
Published: (2003)

Formulas of exaggeration in the Holy Quran
by: Hazim Majeed
Published: (1989-06-01)

USING THE STRATEGY OF EXAGGERATION IN THE COMMUNICATIONS
by: O S Soldatova
Published: (2008-12-01)

Necroptosis in Cholangiocarcinoma
by: Samantha Sarcognato, et al.
Published: (2020-04-01)

Paneth cell dysfunction and the intestinal microbiome in XIAP deficiency
by: Azabdaftari, A, et al.
Published: (2021)

XIAP antagonist embelin inhibited proliferation of cholangiocarcinoma cells.
by: Cody J Wehrkamp, et al.
Published: (2014-01-01)

XIAP protection of photoreceptors in animal models of retinitis pigmentosa.
by: Kevin C Leonard, et al.
Published: (2007-01-01)

Degradation of Bcl-2 by XIAP and ARTS Promotes Apoptosis
by: Natalia Edison, et al.
Published: (2017-10-01)

Identification of an Xiap-like pseudogene on mouse chromosome 7.
by: Aneta Kotevski, et al.
Published: (2009-01-01)

E3 ligase activity of XIAP RING domain is required for XIAP-mediated cancer cell migration, but not for its RhoGDI binding activity.
by: Jinyi Liu, et al.
Published: (2012-01-01)

Individual differences in vocal size exaggeration
by: Michel Belyk, et al.
Published: (2022-02-01)

Consequences of identifying XIAP deficiency in an adult patient with inflammatory bowel disease
by: Quaranta, M, et al.
Published: (2018)

Primary pulmonary lymphoproliferative neoplasms
by: Victoria K Tang, et al.
Published: (2018-01-01)

Facial Resemblance Exaggerates Sex-Specific Jealousy-Based Decisions
by: Steven M. Platek, et al.
Published: (2007-01-01)

CYLD Limits Lys63- and Met1-Linked Ubiquitin at Receptor Complexes to Regulate Innate Immune Signaling
by: Matous Hrdinka, et al.
Published: (2016-03-01)

Hematopoietic cell transplantation for asymptomatic X-linked lymphoproliferative syndrome type 1
by: Akihiro Tamura, et al.
Published: (2018-11-01)

XIAP regulates cytosol-specific innate immunity to Listeria infection.
by: Laura D Bauler, et al.
Published: (2008-08-01)